Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  HIV Infection

  Free Subscription


22.05.2017

7 AIDS
2 AIDS Res Hum Retroviruses
2 Antimicrob Agents Chemother
1 BMC Pediatr
4 Clin Infect Dis
3 HIV Med
6 J Acquir Immune Defic Syndr
1 J Immunol
10 J Infect Dis
3 J Med Virol
4 Lancet HIV
2 Pediatr Infect Dis J
5 PLoS One
1 PLoS Pathog
1 Science
1 Vaccine
2 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. O'MALLEY TK, Burdo TH, Robinson JA, Fitch KV, et al
    Acute hyperinsulinemia effects on systemic markers of immune activation in HIV.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001545.
    PubMed     Text format     Abstract available

  2. BLASER N, Bertisch B, Kouyos RD, Calmy A, et al
    Impact of screening and ART on anal cancer incidence in HIV-positive men who have sex with men: mathematical modeling study.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001546.
    PubMed     Text format     Abstract available

  3. RASMUSSEN TA, McMahon J, Chang JJ, Symons J, et al
    Impact of alemtuzumab on HIV persistence in an HIV-infected individual on antiretroviral therapy with Sezary syndrome.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001540.
    PubMed     Text format     Abstract available

  4. YOUN B, Shireman TI, Lee Y, Galarraga O, et al
    Ten-year trends in anti-retroviral therapy persistence among US medicaid beneficiaries, 2001-2010.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001541.
    PubMed     Text format     Abstract available

  5. TOBIN SC
    Recent Progress in Anti-HIV Broadly Neutralizing Antibody Research.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001544.
    PubMed     Text format    

  6. OMORI R, Abu-Raddad LJ
    Sexual network drivers of HIV and herpes simplex virus type 2 (HSV-2) transmission: a comparative mathematical modeling analysis.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001542.
    PubMed     Text format     Abstract available

  7. ALSAN M, Beshears J, Armstrong WS, Choi JJ, et al
    A commitment contract to achieve virologic suppression in poorly adherent patients with HIV/AIDS.
    AIDS. 2017 May 16. doi: 10.1097/QAD.0000000000001543.
    PubMed     Text format     Abstract available


    AIDS Res Hum Retroviruses

  8. WU Y, Wang H, Ren X, Wan Z, et al
    HIV-1 CRF07_BC with a Seven Amino Acid Deletion in the gag p6 Region Dominates in HIV-1-Infected Men Who Have Sex with Men in China.
    AIDS Res Hum Retroviruses. 2017 May 16. doi: 10.1089/aid.2017.0075.
    PubMed     Text format     Abstract available

  9. FULCHER JA, Romas L, Hoffman JC, Elliott J, et al
    Highly HIV-Exposed Seronegative Men Have Lower Mucosal Innate Immune Reactivity.
    AIDS Res Hum Retroviruses. 2017 May 13. doi: 10.1089/AID.2017.0014.
    PubMed     Text format     Abstract available


    Antimicrob Agents Chemother

  10. STEENS JM, Scherrer D, Gineste P, Barrett PN, et al
    Safety, Pharmacokinetics and_Antiviral Activity of a Novel HIV Antiviral, ABX464, in Treatment- Naive HIV Infected Subjects: a Phase II Randomized, Controlled Study.
    Antimicrob Agents Chemother. 2017 May 15. pii: AAC.00545.
    PubMed     Text format     Abstract available

  11. GIACOBBI NS, Sluis-Cremer N
    In Vitro Cross-Resistance Profiles of Rilpivirine, Dapivirine and MIV-150: NNRTI Microbicides in Clinical Development for the Prevention of HIV-1 Infection.
    Antimicrob Agents Chemother. 2017 May 15. pii: AAC.00277.
    PubMed     Text format     Abstract available


    BMC Pediatr

  12. SHERR L, Macedo A, Tomlinson M, Skeen S, et al
    Could cash and good parenting affect child cognitive development? A cross-sectional study in South Africa and Malawi.
    BMC Pediatr. 2017;17:123.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  13. FOLARANMI TA, Kretz CB, Kamiya H, MacNeil JR, et al
    Increased Risk for Meningococcal Disease among Men who have Sex with Men in the United States, 2012-2015.
    Clin Infect Dis. 2017 May 13. doi: 10.1093.
    PubMed     Text format     Abstract available

  14. JENNESS SM, Weiss KM, Goodreau SM, Gift T, et al
    Incidence of Gonorrhea and Chlamydia Following HIV Preexposure Prophylaxis among Men Who Have Sex with Men: A Modeling Study.
    Clin Infect Dis. 2017 May 13. doi: 10.1093.
    PubMed     Text format     Abstract available

  15. TENFORDE MW, Mokomane M, Leeme T, Patel RKK, et al
    Advanced HIV disease in Botswana following successful antiretroviral therapy rollout: Incidence of and temporal trends in cryptococcal meningitis.
    Clin Infect Dis. 2017 May 13. doi: 10.1093.
    PubMed     Text format     Abstract available

  16. HO EL, Maxwell CL, Dunaway SB, Sahi SK, et al
    Neurosyphilis Increases HIV-associated Central Nervous System Inflammation but Does Not Explain Cognitive Impairment in HIV-infected Individuals with Syphilis.
    Clin Infect Dis. 2017 May 19. doi: 10.1093.
    PubMed     Text format     Abstract available


    HIV Med

  17. LEVY ME, Greenberg AE, Hart R, Powers Happ L, et al
    High burden of metabolic comorbidities in a citywide cohort of HIV outpatients: evolving health care needs of people aging with HIV in Washington, DC.
    HIV Med. 2017 May 15. doi: 10.1111/hiv.12516.
    PubMed     Text format     Abstract available

  18. RIGO F, Cucchetto G, Lanzafame M, Nicole S, et al
    Dual therapy with a combination of unboosted atazanavir and lamivudine as maintenance treatment in virologically suppressed HIV-1-infected patients.
    HIV Med. 2017 May 15. doi: 10.1111/hiv.12523.
    PubMed     Text format    

  19. BOMMART S, Cournil A, Eymard-Duvernay S, Raffi F, et al
    Smoking-associated morbidities on computed tomography lung cancer screens in HIV-infected smokers.
    HIV Med. 2017 May 15. doi: 10.1111/hiv.12517.
    PubMed     Text format    


    J Acquir Immune Defic Syndr

  20. TSAI YT, Chen YC, Hsieh CY, Ko WC, et al
    Incidence of Neurological Disorders among HIV-Infected Individuals with Universal Health Care in Taiwan, 2000 through 2010.
    J Acquir Immune Defic Syndr. 2017 May 17. doi: 10.1097/QAI.0000000000001448.
    PubMed     Text format     Abstract available

  21. DROZD DR, Kitahata MM, Althoff KN, Zhang J, et al
    Increased Risk of Myocardial Infarction in HIV-Infected Individuals in North America Compared to the General Population.
    J Acquir Immune Defic Syndr. 2017 May 17. doi: 10.1097/QAI.0000000000001450.
    PubMed     Text format     Abstract available

  22. BROWN SA, Abbas S, Davies MA, Bunupuradah T, et al
    Pediatric Cancer Burden and Treatment Resources within the Pediatric IeDEA Consortium.
    J Acquir Immune Defic Syndr. 2017 May 17. doi: 10.1097/QAI.0000000000001453.
    PubMed     Text format     Abstract available

  23. KELLY SG, Krueger KM, Grant JL, Penugonda S, et al
    Statin prescribing practices in the comprehensive care for HIV-infected patients.
    J Acquir Immune Defic Syndr. 2017 May 17. doi: 10.1097/QAI.0000000000001454.
    PubMed     Text format    

  24. CHAWANA TD, Gandhi M, Nathoo K, Ngara B, et al
    Defining a cut-off for atazanavir in hair samples associated with virological failure among adolescents failing second-line antiretroviral treatment.
    J Acquir Immune Defic Syndr. 2017 May 17. doi: 10.1097/QAI.0000000000001452.
    PubMed     Text format     Abstract available

  25. VARIAVA E, Sigauke FR, Norman J, Rakgokong M, et al
    Late efavirenz-induced ataxia and encephalopathy: a case series.
    J Acquir Immune Defic Syndr. 2017 May 17. doi: 10.1097/QAI.0000000000001451.
    PubMed     Text format     Abstract available


    J Immunol

  26. FROSCH AE, Odumade OA, Taylor JJ, Ireland K, et al
    Decrease in Numbers of Naive and Resting B Cells in HIV-Infected Kenyan Adults Leads to a Proportional Increase in Total and Plasmodium falciparum-Specific Atypical Memory B Cells.
    J Immunol. 2017 May 19. pii: 1600773. doi: 10.4049/jimmunol.1600773.
    PubMed     Text format     Abstract available


    J Infect Dis

  27. STEINAU M, Gorbach P, Gratzer B, Braxton J, et al
    Concordance between Anal and Oral Human Papillomavirus (HPV) Infections Among Young Men Who Have Sex with Men.
    J Infect Dis. 2017 May 15. doi: 10.1093.
    PubMed     Text format     Abstract available

  28. FERRARI G, Pollara J, Tomaras GD, Haynes BF, et al
    Humoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV Infection.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available

  29. MARGOLIS DM, Archin NM
    Proviral Latency, Persistent Human Immunodeficiency Virus Infection, and the Development of Latency Reversing Agents.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available

  30. MARGOLIS DM
    Towards an HIV Cure: a View of a Developing Field.
    J Infect Dis. 2017;215.
    PubMed     Text format    

  31. MULLINS JI, Frenkel LM
    Clonal Expansion of Human Immunodeficiency Virus-Infected Cells and Human Immunodeficiency Virus Persistence During Antiretroviral Therapy.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available

  32. NIXON CC, Mavigner M, Silvestri G, Garcia JV, et al
    In Vivo Models of Human Immunodeficiency Virus Persistence and Cure Strategies.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available

  33. HENRICH TJ, Deeks SG, Pillai SK
    Measuring the Size of the Latent Human Immunodeficiency Virus Reservoir: The Present and Future of Evaluating Eradication Strategies.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available

  34. RILEY JL, Montaner LJ
    Cell-Mediated Immunity to Target the Persistent Human Immunodeficiency Virus Reservoir.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available

  35. BORITZ EA, Douek DC
    Perspectives on Human Immunodeficiency Virus (HIV) Cure: HIV Persistence in Tissue.
    J Infect Dis. 2017;215.
    PubMed     Text format     Abstract available

  36. HIRAKAWA H, Gatanaga H, Ochi H, Fukuda T, et al
    Antiretroviral therapy containing HIV protease inhibitors enhances fracture risk by impairing osteoblast differentiation and bone quality.
    J Infect Dis. 2017 May 19. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Med Virol

  37. DOS SANTOS MIMA, Rugiere SP, Stocker A, Schinoni MI, et al
    Mutations Associated With Drug Resistance and Prevalence of Vaccine Escape Mutations In Patients With Chronic Hepatitis B Infection.
    J Med Virol. 2017 May 13. doi: 10.1002/jmv.24853.
    PubMed     Text format     Abstract available

  38. LINS L, Farias E, Brites-Alves C, Torres A, et al
    Increased expression of CD38 and HLADR in HIV-infected patients with oral lesion.
    J Med Virol. 2017 May 13. doi: 10.1002/jmv.24852.
    PubMed     Text format     Abstract available

  39. KUANG WD, Zhou YH, Zhong P, Zhang C, et al
    Amino Acids at Positions 3, 168 and 169 are Associated with the Ability of Nef Proteins from HIV-1 CRF01_AE to Downmodulate CD4.
    J Med Virol. 2017 May 13. doi: 10.1002/jmv.24851.
    PubMed     Text format     Abstract available


    Lancet HIV

  40. MAHER L, Dixon TC
    Collateral damage and the criminalisation of drug use.
    Lancet HIV. 2017 May 12. pii: S2352-3018(17)30071.
    PubMed     Text format    

  41. DEBECK K, Cheng T, Montaner JS, Beyrer C, et al
    HIV and the criminalisation of drug use among people who inject drugs: a systematic review.
    Lancet HIV. 2017 May 12. pii: S2352-3018(17)30073.
    PubMed     Text format     Abstract available

  42. KATZ IT, Maughan-Brown B
    Improved life expectancy of people living with HIV: who is left behind?
    Lancet HIV. 2017 May 10. pii: S2352-3018(17)30086.
    PubMed     Text format    


  43. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies.
    Lancet HIV. 2017 May 10. pii: S2352-3018(17)30066.
    PubMed     Text format     Abstract available


    Pediatr Infect Dis J

  44. KEKITIINWA A, Szubert AJ, Spyer M, Katuramu R, et al
    Virologic Response to First-line Efavirenz- or Nevirapine-based Antiretroviral Therapy in HIV-infected African Children.
    Pediatr Infect Dis J. 2017;36:588-594.
    PubMed     Text format     Abstract available

  45. PRASITSUEBSAI W, Sophonphan J, Chokephaibulkit K, Wongsawat J, et al
    Treatment Outcomes of Third-Line Antiretroviral Regimens in HIV-Infected Thai Adolescents.
    Pediatr Infect Dis J. 2017 May 16. doi: 10.1097/INF.0000000000001638.
    PubMed     Text format     Abstract available


    PLoS One

  46. RICCIARDI A, Gentilotti E, Coppola L, Maffongelli G, et al
    Infectious disease ward admission positively influences P. jiroveci pneumonia (PjP) outcome: A retrospective analysis of 116 HIV-positive and HIV-negative immunocompromised patients.
    PLoS One. 2017;12:e0176881.
    PubMed     Text format     Abstract available

  47. STOVER J, Rosen JE, Carvalho MN, Korenromp EL, et al
    The case for investing in the male condom.
    PLoS One. 2017;12:e0177108.
    PubMed     Text format     Abstract available

  48. D'ARMINIO MONFORTE A, Cozzi-Lepri A, Ceccherini-Silberstein F, De Luca A, et al
    Access and response to direct antiviral agents (DAA) in HIV-HCV co-infected patients in Italy: Data from the Icona cohort.
    PLoS One. 2017;12:e0177402.
    PubMed     Text format     Abstract available

  49. MEDLAND NA, Chow EPF, McMahon JH, Elliott JH, et al
    Time from HIV diagnosis to commencement of antiretroviral therapy as an indicator to supplement the HIV cascade: Dramatic fall from 2011 to 2015.
    PLoS One. 2017;12:e0177634.
    PubMed     Text format     Abstract available

  50. ABDULRAHMAN SA, Rampal L, Ibrahim F, Radhakrishnan AP, et al
    Mobile phone reminders and peer counseling improve adherence and treatment outcomes of patients on ART in Malaysia: A randomized clinical trial.
    PLoS One. 2017;12:e0177698.
    PubMed     Text format     Abstract available


    PLoS Pathog

  51. KRAMER B, Goeser F, Lutz P, Glassner A, et al
    Compartment-specific distribution of human intestinal innate lymphoid cells is altered in HIV patients under effective therapy.
    PLoS Pathog. 2017;13:e1006373.
    PubMed     Text format     Abstract available


    Science

  52. BALASUBRAMANI A
    Taking HIV to the gut.
    Science. 2017;356:712-713.
    PubMed     Text format    


    Vaccine

  53. BUCKINGHAM L, Becher J, Voytek CD, Fiore D, et al
    Going social: Success in online recruitment of men who have sex with men for prevention HIV vaccine research.
    Vaccine. 2017 May 16. pii: S0264-410X(17)30587.
    PubMed     Text format     Abstract available


    Virology

  54. ESPY N, Pacheco B, Sodroski J
    Adaptation of HIV-1 to cells with low expression of the CCR5 coreceptor.
    Virology. 2017;508:90-107.
    PubMed     Text format     Abstract available

  55. BELIAKOVA-BETHELL N, Hezareh M, Wong JK, Strain MC, et al
    Relative efficacy of T cell stimuli as inducers of productive HIV-1 replication in latently infected CD4 lymphocytes from patients on suppressive cART.
    Virology. 2017;508:127-133.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: